Scarica l'app Stockscreener
5.72
3.38%
-0.20
Dopo l'orario di chiusura:
5.63
-0.09
-1.57%
Precedente Chiudi:
$5.92
Aprire:
$6
Volume 24 ore:
112.21K
Relative Volume:
1.23
Capitalizzazione di mercato:
$67.37M
Reddito:
$200.00K
Utile/perdita netta:
$-26.17M
Rapporto P/E:
-2.202
EPS:
-2.5976
Flusso di cassa netto:
$-18.64M
1 W Prestazione:
+6.82%
1M Prestazione:
+35.22%
6M Prestazione:
-1.38%
1 anno Prestazione:
+30.89%
Intervallo 1D:
$5.54
$6.525
Intervallo di 1 settimana:
$5.18
$6.525
Portata 52W:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.72 | 67.37M | 200.00K | -26.17M | -18.64M | -2.5976 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
Clene (CLNN) Analyst Rating Maintained at "Buy" with $23 Target - GuruFocus
Clene Nanomedicine "CNM-Au8" Market size expansion of Several Folds by 2034 - openPR.com
Clene (CLNN) Reports FY25 Revenue Beat and Prepares for Key FDA Meeting - GuruFocus
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - Investing News Network
Biopharmaceutical company Clene Inc (CLNN) recently unveiled its new financing strategy—two potential additional financings totaling over $22 millions have completed structural design. This funding plan will enable the company’s operational cash flow to la - Bitget
Clene reports full-year 2025 results: $200k revenue, $26.2M net loss - TradingView
Clene (NASDAQ: CLNN) narrows 2025 loss and readies accelerated ALS NDA filing - Stock Titan
ALS drug CNM-Au8 links biomarker declines to survival, Clene plans FDA filing - Stock Titan
Top Nanotechnology Stocks To Keep An Eye OnMarch 11th - MarketBeat
Nanotechnology Stocks To ConsiderMarch 10th - MarketBeat
Nanotechnology Stocks To Watch TodayMarch 9th - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 8th - MarketBeat
Aug Selloffs: What are the analyst revisions for INCYIs Clene Inc. stock a good investment in YEARNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 7th - MarketBeat
Aug Movers: Should I set a stop loss on Clene IncExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Top Nanotechnology Stocks To ResearchMarch 6th - MarketBeat
Institution Moves: How do insiders feel about Clene IncQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Nanotechnology Stocks To Follow TodayMarch 5th - MarketBeat
Best Nanotechnology Stocks Worth Watching – March 3rd - Defense World
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Nanotechnology Stocks To Follow Today – March 2nd - Defense World
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Top Nanotechnology Stocks To Consider – March 1st - Defense World
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Top Nanotechnology Stocks To ConsiderMarch 1st - MarketBeat
Update Recap: Is Clene Inc a play on infrastructure spendingJuly 2025 Retail & Stock Portfolio Risk Management - baoquankhu1.vn
Top Nanotechnology Stocks To Follow TodayFebruary 28th - MarketBeat
CLNN Should I Buy - Intellectia AI
Best Nanotechnology Stocks To Follow NowFebruary 27th - MarketBeat
Aug Swings: Is LXRX gaining market sharePortfolio Value Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway - MarketBeat
CLNN: Strong biomarker and survival data for ALS therapy positions company for NDA filing and 2027 launch - TradingView
CLNN: Strong biomarker and survival data support accelerated ALS approval, with NDA filing by Q2 - TradingView
CLNN SEC FilingsClene 10-K, 10-Q, 8-K Forms - Stock Titan
Risks Report: What is the Moat Score of Clene IncJuly 2025 Chart Watch & Growth Focused Stock Reports - baoquankhu1.vn
Nanotechnology Stocks To Watch NowFebruary 24th - MarketBeat
Growth Recap: What chart patterns are forming on Clene Inc Equity WarrantWeekly Trade Analysis & AI Enhanced Execution Alerts - baoquankhu1.vn
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts - Investing News Network
Clene outlines 2026 regulatory milestones and ALS strategy - TipRanks
Clene (CLNN) Outlines Key Developments for CNM-Au8 in 2026 - GuruFocus
Clene Inc. Outlines Key Milestones for 2026 - Intellectia AI
Experimental ALS drug CNM-Au8 heads toward 2026 FDA review - Stock Titan
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream - Investing News Network
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8 2026 Catalysts - Bitget
Nanotechnology Stocks Worth WatchingFebruary 23rd - MarketBeat
Chart Watch: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAREarnings Recap Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
[Form 4] Clene Inc. Insider Trading Activity - Stock Titan
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):